A Long-Term Extension Study for Participants With Treatment-resistant Major Depressive Disorder Who Are Continuing Esketamine Nasal Spray Treatment
Clinical trial NCT04829318 · COMPLETED
Trial details
- NCT number
- NCT04829318
- Sponsor
- Janssen-Cilag Ltd.
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2021-04-26
- Primary completion
- 2024-07-22
- Enrollment
- 183
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.